X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-02-11 | PSEC | Prospect Capital Corp | Eliasek M Grier | COO | P - Purchase | $2.92 | +942,800 | 3,443,930 | +38% | +$2,749,770 | ||||||
2026-02-12 | LUCK | Lucky Strike Entertainment Corp | Harinstein Jason | Dir | P - Purchase | $7.54 | +13,000 | 13,000 | New | +$98,020 | ||||||
| M | 2026-02-11 | ONCY | Oncolytics Biotech Inc | Seizinger Bernd R. | Dir | P - Purchase | $0.83 | +100,000 | 566,991 | +21% | +$83,454 | |||||
2026-02-12 | BWFG | Bankwell Financial Group, Inc. | Seidman Lawrence B | Dir | P - Purchase | $48.11 | +1,600 | 792,128 | 0% | +$76,982 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Andrews Patricia S | Dir | P - Purchase | $0.86 | +35,400 | 78,128 | +83% | +$30,292 | ||||||
| M | 2026-02-11 | ONCY | Oncolytics Biotech Inc | Kelly Jared | CEO | P - Purchase | $0.84 | +35,100 | 109,000 | +47% | +$29,521 | |||||
2026-02-11 | ONCY | Oncolytics Biotech Inc | Aromando Andrew | Chief Business Officer | P - Purchase | $0.86 | +29,600 | 55,100 | +116% | +$25,418 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Pisano Wayne | Dir | P - Purchase | $0.84 | +30,000 | 492,414 | +6% | +$25,338 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Brown Deborah Margaret | Dir | P - Purchase | $0.85 | +25,000 | 109,851 | +29% | +$21,240 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Look Kirk | CFO | P - Purchase | $0.84 | +12,000 | 287,515 | +4% | +$10,104 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Heineman Thomas Charles | Chief Medical Officer | P - Purchase | $0.83 | +12,132 | 282,818 | +4% | +$10,033 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Hagerman Allison | VP, Product Development | P - Purchase | $0.83 | +10,000 | 115,059 | +10% | +$8,298 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |